Contact
searchSearch
HMP Global

Interventional Oncology

Features

New Technique
Preoperative Devascularization of Large Neck Tumors Encasing the Internal Carotid Artery Using Hybrid Trapping Technique
06/08/2026
Rajat Singhal, DM, DNB, FRCR, EBIR; Rajchandra Singh Kharayat, DM, DNB; L. Samuel Prabhu Mithra, MCh, MS; Deepak Selvaraj, MCh, MS, MRCS; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
The authors describe a novel “technique of hybrid trapping” in a 32-year-old man with a Shamblin III carotid body tumor encasing the internal carotid artery.
The authors describe a novel “technique of hybrid trapping” in a 32-year-old man with a Shamblin III carotid body tumor encasing the internal carotid artery.
The authors describe a novel...
06/08/2026
Vascular Disease Management
Histotripsy
Histotripsy Adoption in Interventional Oncology Presents Opportunities and Challenges in the United Kingdom
06/03/2026
Laura Simson, MA
06/03/2026
Vascular Disease Management
Clinical Trials
Surrogate Endpoints Remain a Challenge in Interventional Oncology Trials
05/12/2026
Laura Simson, MA
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined...
05/12/2026
Vascular Disease Management
Novel Local Therapies
Pulsed Electric Field Ablation Plus SBRT Preserves Quality of Life in Lung Tumors
04/13/2026
Laura Simson, MA
A prospective pilot study evaluated the impact of a novel combination of pulsed electric field ablation and stereotactic body radiation therapy on health-related quality of life and pulmonary function in patients with oligometastatic or...
A prospective pilot study evaluated the impact of a novel combination of pulsed electric field ablation and stereotactic body radiation therapy on health-related quality of life and pulmonary function in patients with oligometastatic or...
A prospective pilot study...
04/13/2026
Vascular Disease Management
AML TUMORS
Fluidx Medical Announces First Patient Treated with Novel Embolic Gel
04/01/2026
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. 
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. 
Gel embolic device designed to...
04/01/2026
Vascular Disease Management
Interview
Advancing AI in IO: Dr Dania Daye on Improving Research Quality, Clinical Outcomes, and Patient Care
03/13/2026
Dania Daye, MD, PhD
Dr Dania Daye discusses the need for standardized reporting in AI studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need for standardized reporting in AI studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need...
03/13/2026
Vascular Disease Management
AI in IO title slide
Video
Advancing AI in IO: Improving Research Quality, Clinical Outcomes, and Patient Care
03/13/2026
Dania Daye, MD, PhD
Dr Dania Daye discusses the need for standardized reporting in artificial intelligence (AI) studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need for standardized reporting in artificial intelligence (AI) studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need...
03/13/2026
Vascular Disease Management
VDM logo
Analysis
Artificial Intelligence Advances in Interventional Oncology: Year in Review
02/23/2026
Laura Simson, MA
02/23/2026
Vascular Disease Management
Society of Interventional Oncology logo
SIO 2026
SIO 2026 Spotlights Pain Palliation, Pressure Monitoring, Technological Innovation
02/06/2026
Laura Simson, MA
Highlights from SIO 2026, the Society of Interventional Oncology Annual Scientific Meeting.
Highlights from SIO 2026, the Society of Interventional Oncology Annual Scientific Meeting.
Highlights from SIO 2026, the...
02/06/2026
Vascular Disease Management
VDM logo
Quiz
Ablation Update: Key Concepts for Interventional Practice
01/29/2026
How well do you know today’s ablation landscape? Put your expertise to the test!
How well do you know today’s ablation landscape? Put your expertise to the test!
How well do you know today’s...
01/29/2026
Vascular Disease Management
CIO logo
CIO 2025
Current Status of Histotripsy: Liver, Renal, and Beyond
01/29/2026
Laura Simson, MA
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal...
01/29/2026
Vascular Disease Management

Videos

AI in IO title slide
Video
Advancing AI in IO: Improving Research Quality, Clinical Outcomes, and Patient Care
03/13/2026
Dania Daye, MD, PhD
Dr Dania Daye discusses the need for standardized reporting in artificial intelligence (AI) studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need for standardized reporting in artificial intelligence (AI) studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need...
03/13/2026
Vascular Disease Management
Stumetz headshot
CIO 2025
Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes
11/25/2025
Kyle S. Stumetz, DO; Laura Simson, MA
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the...
11/25/2025
Vascular Disease Management
Dr Prologo
Sponsored Video
Dual-Level Kyphoplasty With OsteoCool 2.0: Simultaneous Ablation and Cementation Guided by Dr Prologo
09/26/2025
J. David Prologo, MD, FSIR
Join Dr Prologo for a groundbreaking look at a dual-level kyphoplasty procedure using the OsteoCool 2.0 system. This exclusive video captures real-time ablation and cement injection at two vertebral levels with 10-gauge cannulas, complete...
Join Dr Prologo for a groundbreaking look at a dual-level kyphoplasty procedure using the OsteoCool 2.0 system. This exclusive video captures real-time ablation and cement injection at two vertebral levels with 10-gauge cannulas, complete...
Join Dr Prologo for a...
09/26/2025
Vascular Disease Management
JLevy headshot
Video
Percutaneous Ablation for Vertebral Metastases
08/11/2025
Jason Levy, MD, FSIR
Dr Jason Levy discusses the clinical considerations, procedural techniques, and the ongoing evidence in the use of percutaneous ablation for treating vertebral metastases.
Dr Jason Levy discusses the clinical considerations, procedural techniques, and the ongoing evidence in the use of percutaneous ablation for treating vertebral metastases.
Dr Jason Levy discusses the...
08/11/2025
Vascular Disease Management
McArthur image
Video
Perioperative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-Negative Breast Cancer
06/26/2025
Heather McArthur, MD, MPH
Dr Heather McArthur speaks about her work examining the impact of perioperative cryoablation and immune checkpoint inhibition on 3-year event-free survival in women with TNBC after taxane-based neoadjuvant chemotherapy.
Dr Heather McArthur speaks about her work examining the impact of perioperative cryoablation and immune checkpoint inhibition on 3-year event-free survival in women with TNBC after taxane-based neoadjuvant chemotherapy.
Dr Heather McArthur speaks about...
06/26/2025
Vascular Disease Management
Dr Setayesh Sotoudehnia
Video
Making the Impossible Possible: MR-Guided Interventional Oncology
03/27/2025
Setayesh Sotoudehnia, MD
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh...
03/27/2025
Vascular Disease Management
Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Dr Wiechmann
OBL Corner
Why Embolotherapy Is Ideal for the Office-based Lab
03/10/2025
Bret N. Wiechmann, MD, FSIR, FAHA
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a...
03/10/2025
Vascular Disease Management
Sirtex Sponsored Video
Sponsored video
Optimization of SIR-Spheres® Y-90 Resin Microspheres for Personalized Treatment Intent
11/11/2024
This Sirtex sponsored symposium features Dr. Nima Kokabi MD and moderated by Dr. Asad Baig MD, and delves into the fundamentals of Y-90 dosimetry crucial for maximizing therapeutic outcomes with SIR-Spheres Y-90 resin microspheres.
This Sirtex sponsored symposium features Dr. Nima Kokabi MD and moderated by Dr. Asad Baig MD, and delves into the fundamentals of Y-90 dosimetry crucial for maximizing therapeutic outcomes with SIR-Spheres Y-90 resin microspheres.
This Sirtex sponsored symposium...
11/11/2024
Vascular Disease Management
Dr Edward Kim
Sponsored video
The Wave of the Future: New Technologies for the IR
10/18/2024
At the 2024 CIO, Ed Kim, MD, moderated a session titled “The Wave of the Future: New Technologies or the IR”, featuring presentations on conformable embolic and robotics by Dr Kim, Osman Ahmed, MD, and Gina Landinez, MD.
At the 2024 CIO, Ed Kim, MD, moderated a session titled “The Wave of the Future: New Technologies or the IR”, featuring presentations on conformable embolic and robotics by Dr Kim, Osman Ahmed, MD, and Gina Landinez, MD.
At the 2024 CIO, Ed Kim, MD,...
10/18/2024
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Surmodics Video Presentation
Sponsored VIdeo
#POUNCEIT! Watch Now: AMP Symposium Videos
03/26/2026
Fadi Saab, MD, FACC, FSCAI; Mahmood Razavi, MD; Lucas Ferrer Cardona, MD; Miguel Montero-Baker, MD; Dean Ferrera, DO; Stylianos Papadakos, MD
Watch the Amputation Prevention Symposium session as an expert panel of physicians present cases and discuss their experiences capturing acute or chronic clot in ATK and BTK peripheral arteries with the Pounce™ Thrombectomy Platform.
Watch the Amputation Prevention Symposium session as an expert panel of physicians present cases and discuss their experiences capturing acute or chronic clot in ATK and BTK peripheral arteries with the Pounce™ Thrombectomy Platform.
Watch the Amputation Prevention...
03/26/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Sanjay Misra speaks at ISET 2026
ISET 2026
Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes
03/25/2026
Sanjay Misra, MD, FSIR, FAHA, FACR
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist...
03/25/2026
Vascular Disease Management
Dr William Gray speaking at ISET
ISET 2026
Three-Year Outcomes from the PERFORMANCE II Trial: A Prospective Multicenter Study of the Neuroguard IEP® 3-in-1 Carotid Stent System
03/24/2026
William A. Gray, MD, FACC, FSCAI
Dr. Gray reviews the study’s design, clinical endpoints, and 3-year results, offering insight into safety, efficacy, and sustained performance.
Dr. Gray reviews the study’s design, clinical endpoints, and 3-year results, offering insight into safety, efficacy, and sustained performance.
Dr. Gray reviews the study’s...
03/24/2026
Vascular Disease Management

Conference Coverage

VDM logo
SIO 2026
Abstracts Presented at SIO 2026 Highlight Advances in Y-90 Radioembolization
03/02/2026
Laura Simson, MA
The yttrium-90 (Y-90) abstracts presented at Society of Interventional Oncology (SIO) 2026 Annual Scientific Meeting reflect the expanding role of transarterial radioembolization and radiation segmentectomy across a spectrum of hepatic and...
The yttrium-90 (Y-90) abstracts presented at Society of Interventional Oncology (SIO) 2026 Annual Scientific Meeting reflect the expanding role of transarterial radioembolization and radiation segmentectomy across a spectrum of hepatic and...
The yttrium-90 (Y-90) abstracts...
03/02/2026
Vascular Disease Management
Society of Interventional Oncology logo
SIO 2026
SIO 2026 Spotlights Pain Palliation, Pressure Monitoring, Technological Innovation
02/06/2026
Laura Simson, MA
Highlights from SIO 2026, the Society of Interventional Oncology Annual Scientific Meeting.
Highlights from SIO 2026, the Society of Interventional Oncology Annual Scientific Meeting.
Highlights from SIO 2026, the...
02/06/2026
Vascular Disease Management
CIO logo
CIO 2025
Current Status of Histotripsy: Liver, Renal, and Beyond
01/29/2026
Laura Simson, MA
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal...
01/29/2026
Vascular Disease Management
Interview
Radiation Therapy Alone vs Radiation Therapy Plus Radiofrequency Ablation/Vertebral Augmentation for Painful Spine Metastasis: A Phase 2 Randomized Controlled Trial
01/15/2026
Brian J. Schiro, MD
Brian Schiro, MD, winner of the Best Poster Award at CIO 2025, discusses his study on radiation therapy vs radiation therapy plus radiofrequency ablation.
Brian Schiro, MD, winner of the Best Poster Award at CIO 2025, discusses his study on radiation therapy vs radiation therapy plus radiofrequency ablation.
Brian Schiro, MD, winner of the...
01/15/2026
Vascular Disease Management
Stumetz headshot
CIO 2025
Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes
11/25/2025
Kyle S. Stumetz, DO; Laura Simson, MA
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the...
11/25/2025
Vascular Disease Management
CIO image
CIO 2025
Y90: Year in Review
11/12/2025
Laura Simson, MA
At CIO 2025, Dr Robert J. Lewandowski presented “Y90: Year in Review,” a comprehensive update on advances in yttrium-90 (Y-90) radioembolization across hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver disease.
At CIO 2025, Dr Robert J. Lewandowski presented “Y90: Year in Review,” a comprehensive update on advances in yttrium-90 (Y-90) radioembolization across hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver disease.
At CIO 2025, Dr Robert J....
11/12/2025
Vascular Disease Management
RGandhi
CIO 2025
Y90 Dosimetry Pre-Conference Training for Interventional Oncology in Miami Beach
09/26/2025
Ripal Gandhi, MD
In advance of the 2025 Symposium on Clinical Interventional Oncology (CIO), Ripal Gandhi, MD, speaks about the Y90 Dosimetry Pre-Conference, an immersive workshop designed to deepen clinicians’ expertise in Y90 radioembolization dosimetry.
In advance of the 2025 Symposium on Clinical Interventional Oncology (CIO), Ripal Gandhi, MD, speaks about the Y90 Dosimetry Pre-Conference, an immersive workshop designed to deepen clinicians’ expertise in Y90 radioembolization dosimetry.
In advance of the 2025 Symposium...
09/26/2025
Vascular Disease Management
BO_IP_headshots
SIO 2025
An Exciting Frontier: The Rise of Robotics in Interventional Oncology
01/29/2025
Bruno C. Odisio, MD, PhD, FSIR, FCIRSE; Iwan Paolucci, PhD
In advance of the 2025 SIO conference, Dr Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, and Iwan Paolucci, PhD, spoke with VDM about their upcoming sessions on Robotics, Navigation, Guidance, and Confirmation.
In advance of the 2025 SIO conference, Dr Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, and Iwan Paolucci, PhD, spoke with VDM about their upcoming sessions on Robotics, Navigation, Guidance, and Confirmation.
In advance of the 2025 SIO...
01/29/2025
Vascular Disease Management
Sirtex Sponsored Video
Sponsored video
Optimization of SIR-Spheres® Y-90 Resin Microspheres for Personalized Treatment Intent
11/11/2024
This Sirtex sponsored symposium features Dr. Nima Kokabi MD and moderated by Dr. Asad Baig MD, and delves into the fundamentals of Y-90 dosimetry crucial for maximizing therapeutic outcomes with SIR-Spheres Y-90 resin microspheres.
This Sirtex sponsored symposium features Dr. Nima Kokabi MD and moderated by Dr. Asad Baig MD, and delves into the fundamentals of Y-90 dosimetry crucial for maximizing therapeutic outcomes with SIR-Spheres Y-90 resin microspheres.
This Sirtex sponsored symposium...
11/11/2024
Vascular Disease Management
Dr Edward Kim
Sponsored video
The Wave of the Future: New Technologies for the IR
10/18/2024
At the 2024 CIO, Ed Kim, MD, moderated a session titled “The Wave of the Future: New Technologies or the IR”, featuring presentations on conformable embolic and robotics by Dr Kim, Osman Ahmed, MD, and Gina Landinez, MD.
At the 2024 CIO, Ed Kim, MD, moderated a session titled “The Wave of the Future: New Technologies or the IR”, featuring presentations on conformable embolic and robotics by Dr Kim, Osman Ahmed, MD, and Gina Landinez, MD.
At the 2024 CIO, Ed Kim, MD,...
10/18/2024
Vascular Disease Management
VDM logo
SIO 2026
Abstracts Presented at SIO 2026 Highlight Advances in Y-90 Radioembolization
03/02/2026
Laura Simson, MA
The yttrium-90 (Y-90) abstracts presented at Society of Interventional Oncology (SIO) 2026 Annual Scientific Meeting reflect the expanding role of transarterial radioembolization and radiation segmentectomy across a spectrum of hepatic and...
The yttrium-90 (Y-90) abstracts presented at Society of Interventional Oncology (SIO) 2026 Annual Scientific Meeting reflect the expanding role of transarterial radioembolization and radiation segmentectomy across a spectrum of hepatic and...
The yttrium-90 (Y-90) abstracts...
03/02/2026
Vascular Disease Management
Society of Interventional Oncology logo
SIO 2026
SIO 2026 Spotlights Pain Palliation, Pressure Monitoring, Technological Innovation
02/06/2026
Laura Simson, MA
Highlights from SIO 2026, the Society of Interventional Oncology Annual Scientific Meeting.
Highlights from SIO 2026, the Society of Interventional Oncology Annual Scientific Meeting.
Highlights from SIO 2026, the...
02/06/2026
Vascular Disease Management
CIO logo
CIO 2025
Current Status of Histotripsy: Liver, Renal, and Beyond
01/29/2026
Laura Simson, MA
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal...
01/29/2026
Vascular Disease Management
Interview
Radiation Therapy Alone vs Radiation Therapy Plus Radiofrequency Ablation/Vertebral Augmentation for Painful Spine Metastasis: A Phase 2 Randomized Controlled Trial
01/15/2026
Brian J. Schiro, MD
Brian Schiro, MD, winner of the Best Poster Award at CIO 2025, discusses his study on radiation therapy vs radiation therapy plus radiofrequency ablation.
Brian Schiro, MD, winner of the Best Poster Award at CIO 2025, discusses his study on radiation therapy vs radiation therapy plus radiofrequency ablation.
Brian Schiro, MD, winner of the...
01/15/2026
Vascular Disease Management
Stumetz headshot
CIO 2025
Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes
11/25/2025
Kyle S. Stumetz, DO; Laura Simson, MA
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the...
11/25/2025
Vascular Disease Management
CIO image
CIO 2025
Y90: Year in Review
11/12/2025
Laura Simson, MA
At CIO 2025, Dr Robert J. Lewandowski presented “Y90: Year in Review,” a comprehensive update on advances in yttrium-90 (Y-90) radioembolization across hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver disease.
At CIO 2025, Dr Robert J. Lewandowski presented “Y90: Year in Review,” a comprehensive update on advances in yttrium-90 (Y-90) radioembolization across hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver disease.
At CIO 2025, Dr Robert J....
11/12/2025
Vascular Disease Management
RGandhi
CIO 2025
Y90 Dosimetry Pre-Conference Training for Interventional Oncology in Miami Beach
09/26/2025
Ripal Gandhi, MD
In advance of the 2025 Symposium on Clinical Interventional Oncology (CIO), Ripal Gandhi, MD, speaks about the Y90 Dosimetry Pre-Conference, an immersive workshop designed to deepen clinicians’ expertise in Y90 radioembolization dosimetry.
In advance of the 2025 Symposium on Clinical Interventional Oncology (CIO), Ripal Gandhi, MD, speaks about the Y90 Dosimetry Pre-Conference, an immersive workshop designed to deepen clinicians’ expertise in Y90 radioembolization dosimetry.
In advance of the 2025 Symposium...
09/26/2025
Vascular Disease Management
BO_IP_headshots
SIO 2025
An Exciting Frontier: The Rise of Robotics in Interventional Oncology
01/29/2025
Bruno C. Odisio, MD, PhD, FSIR, FCIRSE; Iwan Paolucci, PhD
In advance of the 2025 SIO conference, Dr Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, and Iwan Paolucci, PhD, spoke with VDM about their upcoming sessions on Robotics, Navigation, Guidance, and Confirmation.
In advance of the 2025 SIO conference, Dr Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, and Iwan Paolucci, PhD, spoke with VDM about their upcoming sessions on Robotics, Navigation, Guidance, and Confirmation.
In advance of the 2025 SIO...
01/29/2025
Vascular Disease Management
Sirtex Sponsored Video
Sponsored video
Optimization of SIR-Spheres® Y-90 Resin Microspheres for Personalized Treatment Intent
11/11/2024
This Sirtex sponsored symposium features Dr. Nima Kokabi MD and moderated by Dr. Asad Baig MD, and delves into the fundamentals of Y-90 dosimetry crucial for maximizing therapeutic outcomes with SIR-Spheres Y-90 resin microspheres.
This Sirtex sponsored symposium features Dr. Nima Kokabi MD and moderated by Dr. Asad Baig MD, and delves into the fundamentals of Y-90 dosimetry crucial for maximizing therapeutic outcomes with SIR-Spheres Y-90 resin microspheres.
This Sirtex sponsored symposium...
11/11/2024
Vascular Disease Management
Dr Edward Kim
Sponsored video
The Wave of the Future: New Technologies for the IR
10/18/2024
At the 2024 CIO, Ed Kim, MD, moderated a session titled “The Wave of the Future: New Technologies or the IR”, featuring presentations on conformable embolic and robotics by Dr Kim, Osman Ahmed, MD, and Gina Landinez, MD.
At the 2024 CIO, Ed Kim, MD, moderated a session titled “The Wave of the Future: New Technologies or the IR”, featuring presentations on conformable embolic and robotics by Dr Kim, Osman Ahmed, MD, and Gina Landinez, MD.
At the 2024 CIO, Ed Kim, MD,...
10/18/2024
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Histotripsy
Histotripsy Adoption in Interventional Oncology Presents Opportunities and Challenges in the United Kingdom
06/03/2026
Laura Simson, MA
06/03/2026
Vascular Disease Management
Clinical Trials
Surrogate Endpoints Remain a Challenge in Interventional Oncology Trials
05/12/2026
Laura Simson, MA
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined...
05/12/2026
Vascular Disease Management
Novel Local Therapies
Pulsed Electric Field Ablation Plus SBRT Preserves Quality of Life in Lung Tumors
04/13/2026
Laura Simson, MA
A prospective pilot study evaluated the impact of a novel combination of pulsed electric field ablation and stereotactic body radiation therapy on health-related quality of life and pulmonary function in patients with oligometastatic or...
A prospective pilot study evaluated the impact of a novel combination of pulsed electric field ablation and stereotactic body radiation therapy on health-related quality of life and pulmonary function in patients with oligometastatic or...
A prospective pilot study...
04/13/2026
Vascular Disease Management
AML TUMORS
Fluidx Medical Announces First Patient Treated with Novel Embolic Gel
04/01/2026
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. 
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. 
Gel embolic device designed to...
04/01/2026
Vascular Disease Management
VDM logo
Analysis
Artificial Intelligence Advances in Interventional Oncology: Year in Review
02/23/2026
Laura Simson, MA
02/23/2026
Vascular Disease Management
VDM logo
News
Medicare Updates to Reshape Interventional Oncology Reimbursement in 2026
11/11/2025
Laura Simson, MA
11/11/2025
Vascular Disease Management
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management
Press Release
Inaugural Global Symposium on Interventional Radiation Protection to Focus on Keeping Lab-Based Clinicians Safe
05/13/2025
The live online symposium will be held September 26-27, 2025. While radiation protection is discussed at other conferences, SIRP is the first program dedicated entirely to radiation safety with a goal of reducing the number of...
The live online symposium will be held September 26-27, 2025. While radiation protection is discussed at other conferences, SIRP is the first program dedicated entirely to radiation safety with a goal of reducing the number of...
The live online symposium will...
05/13/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Press Release
First-in-Human Clinical Success with Novel Mechanical Thrombectomy System
06/09/2026
SALT LAKE CITY, UT, June 09, 2026 /24-7PressRelease/ -- Ventiv Scientific today announced the successful completion of its first-in-human (FIH) clinical cases utilizing the V-PULSE™ Mechanical Thrombectomy System, a novel thrombectomy...
SALT LAKE CITY, UT, June 09, 2026 /24-7PressRelease/ -- Ventiv Scientific today announced the successful completion of its first-in-human (FIH) clinical cases utilizing the V-PULSE™ Mechanical Thrombectomy System, a novel thrombectomy...
SALT LAKE CITY, UT, June 09,...
06/09/2026
Vascular Disease Management
Histotripsy
Histotripsy Adoption in Interventional Oncology Presents Opportunities and Challenges in the United Kingdom
06/03/2026
Laura Simson, MA
06/03/2026
Vascular Disease Management
Drug-Coated Balloons
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
06/02/2026
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s...
06/02/2026
Cath Lab Digest
Thrombectomy
Endologix Acquires Pounce™ Thrombectomy System, Expanding Its Vascular Intervention Portfolio
05/20/2026
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS...
05/20/2026
Vascular Disease Management
Intravascular Lithotripsy
Cagent Vascular Reports First Human Use of Serranator® SONIC IVL System and Closes Oversubscribed $41M Series D Financing
05/19/2026
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical...
05/19/2026
Vascular Disease Management
Arterial and Venous Embolization
Medtronic Announces Successful Early Commercial Use of Concerto Versa™ Detachable Coil
05/18/2026
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully...
05/18/2026
Vascular Disease Management
Clinical Trials
Surrogate Endpoints Remain a Challenge in Interventional Oncology Trials
05/12/2026
Laura Simson, MA
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined...
05/12/2026
Vascular Disease Management
IVUS+OCT
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
05/08/2026
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and...
05/08/2026
Cath Lab Digest
Stroke
Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service
05/05/2026
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK –...
05/05/2026
Vascular Disease Management
Pulmonary embolism
Thrombolex Announces Enrollment of 100th Patient in RAPID-PE Clinical Study
05/01/2026
Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...
Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...
Landmark Milestone Reached in...
05/01/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use